Knowledge the results of psychedelics on human brain networks is critical to unlocking their therapeutic mechanisms. In individuals, over the around 6?hour length of motion, psilocybin boosts glutamate signalling and glucose metabolism19,20,21, broadly decreases the power of electrophysiological signals22, reduces hemodynamic fluctuations23 and dec